Last updated: May 19, 2022
Sponsor: University Hospital Tuebingen
Overall Status: Active - Recruiting
Phase
N/A
Condition
Neuronal Ceroid Lipofuscinoses (Ncl)
Holoprosencephaly
Treatment
N/AClinical Study ID
NCT03491280
DiRiP-RD
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Unclear diagnosis
- Suspected genetic cause of the disease
Exclusion
Exclusion Criteria:
- Missing informed consent of the patient/ legal guardian
Study Design
Total Participants: 5500
Study Start date:
May 01, 2018
Estimated Completion Date:
April 30, 2025
Study Description
Connect with a study center
University Hospital
Tübingen, 72076
GermanyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.